Given the elevated levels of endogenous ligands, LPIs, in the blood of rheumatoid arthritis patients [4], it is plausible that the activation of GPR55 by LPIs contributes to inflammatory and autoimmune processes, as demonstrated through the use of the GPR55 antagonist CID16020046 in this study. Here, GPR55 is linked to rheumatoid arthritis.